TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS

Area of Science:

• Molecular Biology
• Cancer Research
• Endocrinology

Background:

• Estrogen signaling is implicated in breast epithelial cell proliferation and mammary tumorigenesis.
• Selective Estrogen Receptor Modulators (SERMs) are used in breast cancer treatment and prevention.
• Oxidative stress and DNA damage are key factors in estrogen-induced cancer development.

Purpose of the Study:

• To investigate the role of SERMs in upregulating antioxidative stress enzymes in breast epithelial cells.
• To identify the molecular mechanisms and key proteins involved in SERM-mediated protection against estrogen genotoxicity.
• To elucidate the function of the human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2) in this pathway.

Main Methods:

• Utilized breast epithelial cell lines for in vitro studies.
• Assessed the expression levels of antioxidative stress enzymes.
• Investigated the requirement of Estrogen Receptor beta (ERβ) and hPMC2 for SERM effects.
• Examined the functional exonuclease domain of hPMC2.

Main Results:

• SERMs upregulate antioxidative stress enzymes in breast epithelial cells.
• This upregulation is dependent on both ERβ and hPMC2.
• hPMC2 possesses a functional exonuclease domain essential for this process.
• hPMC2's exonuclease activity is required for repairing estrogen-induced abasic sites.

Conclusions:

• SERMs confer protection against estrogen's genotoxic effects and mammary tumorigenesis through ERβ and hPMC2.
• hPMC2 plays a critical role in upregulating antioxidative stress enzymes and repairing DNA damage induced by estrogens.
• The findings highlight a novel mechanism of chemoprevention involving ERβ, hPMC2, and antioxidative pathways.